Metsera

Developing next-gen obesity therapies

Measuring tape on top of cash
Biotech

Pfizer inks $4.9B Metsera buyout to beef up obesity pipeline

Having seen its internal assets flounder, the Big Pharma has struck a deal to buy Metsera for to secure a pipeline of injectable and oral candidates.
Nick Paul Taylor Sep 22, 2025 7:47am
obesity overweight weight loss weigh

Metsera posts amylin data, eyes monthly GLP-1 combo

Jun 9, 2025 7:00am
biotechs top money raisers hero image

Biotech's top money raisers: 2024

Mar 3, 2025 5:00am
Photo of Wall Street street sign with american flags in the background

Metsera, Maze go public with IPOs of $275M, $113M

Jan 31, 2025 7:40am
finance numbers tape money

Metsera eyes $289M IPO to fund phase 3 weight loss trial

Jan 27, 2025 11:00am
IPO art

Obesity biotech Metsera files for a swift IPO

Jan 11, 2025 9:05am